#preventdiseases

We have a chronic disease epidemic. We wonder why we are losing so many people to preventable diseases. We treat them with medicines and procedures and this does not provide lasting results. They get worse and they die. Many live with lots of medicines to sustain them. How can we change this trend?...

Not only will eating well, exercising regularly, and cutting out junk food help your health and longevity, but it will also leave you looking and feeling younger. It will improve your state of mind and body.

However, it is challenging to form healthy routines because of the required mental shifts. A healthy lifestyle is possible with the right motivation and focus. Most of us have some health problems. Being overweight, unstable moods, illness, lack of energy, and lack of appearance are typical health problems. Adopting a healthy lifestyle is crucial in fighting these problems.

Well-Being and Health's Crucial Role:

The following arguments will show you why health and wellness are so crucial:

Weight management: You can keep the weight off with regular exercise and a good diet. You can't lose weight, strengthen your immune system, or feel more energized without regular physical activity.

To maintain your current level of physical fitness, you should exercise for at least 150 minutes every week. Combine regular exercise with a healthy, low-calorie diet. Getting the right amount of carbohydrates, lipids, and proteins can provide you with a sustained burst of energy throughout the day.

Improve mood: Adopting a healthy lifestyle might help you feel calm and refreshed all day. Improve your disposition and gain confidence via regular exercise and a balanced diet. Stress relief is an added benefit.

Prevent diseases: A healthy lifestyle can help you avoid health problems like heart disease, high blood pressure, depression, chronic pain, and more. Eat a good breakfast every morning. A higher metabolic rate is only one of the many benefits of a healthy lifestyle that includes regular exercise and a balanced diet.

Increase vitality: A lack of energy is a direct result of a poor diet. However, if you eat healthily, your body will have the fuel to perform all its tasks. Whole grains, lean meats, low-fat dairy, and fruits and vegetables are all staples of a healthy diet. A good night's sleep and a healthy, well-balanced breakfast will set the tone for a productive day.

Improves longevity: Adopting a healthy lifestyle in your daily routine will also increase your life expectancy, skin health, hair health, and general health and wellness.

The key to a healthy lifestyle, including all the above advantages, is regular exercise and a balanced diet. A five-minute stroll is a good place to start if you want a healthy body. Start with 30 minutes every day and work your way up.

Conclusion:

Meningococcal vaccine is used to prevent diseases caused due to Neisseria meningitidis, also known as meningococcus, is a Gram-negative bacterium that can cause meningitis and other forms of meningococcal disease such as meningococcemia.

The global meningococcal vaccines market is estimated to account for US$ 3,341.9 Mn in terms of value and is expected to reach US$ 7,732.3 Mn by the end of 2027.

Global Meningococcal Vaccines Market: Drivers

Significant number of people travelling to sub-Saharan Africa is expected to propel growth of the global meningococcal vaccines market over the forecast period. For instance, according to World Economic Forum’s, 2018 report, 37.4 million tourist arrivals were recorded in Sub-Saharan Africa in 2017.

Moreover, recommendation of various regulatory bodies for meningococcal vaccination is also expected to aid in growth of the market. For instance, the Centers for Disease Control and Prevention recommends meningococcal vaccines for preteens, teens, and certain other people.

North America held dominant position in the global meningococcal vaccines market in 2019, accounting for 36.8% share in terms of value, followed by Asia Pacific and Europe respectively.

Figure 1. Global Meningococcal Vaccines Market Share (%), by Value, by Region, 2019

Global Meningococcal Vaccines Market: Restraints

Significant variations in the incidences and epidemiology of meningococcal disease have been observed both geographically and over time. Thus, broad coverage targeting as many serogroups as possible is needed. The risk associated with travelers is unpredictable making it more difficult to provide evidence-based vaccine recommendations. Such scenario is expected to hinder growth of the market.

Moreover, meningococcal vaccination is optional in several countries, which is also expected to limit the market growth.  

Global Meningococcal Vaccines Market: Opportunities 

Development of vaccines that do not depend on very narrow range temperatures for storage is expected to offer lucrative growth opportunities for players in the market. Till date, there is only one meningococcal vaccine- MenAfriVac that has been approved for use outside the cold chain.

Development of vaccines through collaborations and public private partnerships is also expected to aid in market growth. The innovative MenAfriVac meningococcal vaccine was developed through collaboration between the PATH-WHO Meningitis Vaccine Project, an Indian vaccine manufacturer Serum Institute of India Ltd., and public health officials in India and several African countries. The development was aimed at providing an effective, long-term, and affordable solution to epidemics caused due to meningococcal disease in the African meningitis belt. Such initiatives are expected to aid in development of affordable meningococcal vaccines.

The global meningococcal vaccines market was valued at US$ 2,965.9 Mn in 2019 and is forecast to reach a value of US$ 7,732.3 Mn by 2027 at a CAGR of 12.7% between 2020 and 2027.

Figure 2. Global Meningococcal Vaccines Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Market Trends/Key Takeaways

In Europe, there is low meningococcal vaccination coverage among children up to five years old and there is also knowledge gaps about invasive meningococcal disease. For instance, according to the study, ‘Parental Knowledge about Meningococcal Disease and Vaccination Uptake among 0–5 years Old Polish Children,’ published in International Journal of Environmental Research and Public Health, in January 2019, only 18.8% of parents self-assessed their knowledge regarding invasive meningococcal disease as good. Knowledge regarding the disease was higher among parents with higher educational level.

Moreover, awareness regarding meningococcal b vaccine among pediatricians in Italy was found to be low. For instance, according to the study, ‘Awareness, Attitudes, and Practices Toward Meningococcal B Vaccine among Pediatricians in Italy’, published in December 2018, only 28.0% knew the vaccination schedule for meningococcal B serogroup for children aged two years or under.

Regulations

U.S.

The approval of any vaccine in the U.S. is an extensive process that requires submission of a Biologics License Application (BLA) by the vaccine manufacturer.

The FDA medical and scientific staff then executes a detailed assessment of data supporting the safety and effectiveness of the vaccine, and quality of the manufacturing process.

Global Meningococcal Vaccines Market: Competitive Landscape

Major players operating in the global meningococcal vaccines market include, Baxter International, Inc., Biomed Pvt. Ltd., GlaxoSmithKline plc, JN-International Medical Corporation, Novartis International AG., Pfizer, Inc., Sanofi SA, and Serum Institute of India Ltd.

Global Meningococcal Vaccines Market: Key Developments

Major players in the market are focused on approval and launch of new vaccines to expand their product portfolio. For instance, in April 2020, The U.S. Food and Drug Administration (FDA) granted a Biologics License Application for Sanofi’s MenQuadfi Meningococcal (Groups A, C, Y, W) Conjugate Vaccine for the prevention of invasive meningococcal disease in persons 2 years of age and older.

Major players in the market are also focused on expanding their production capacity. For instance, in September 2019, Serum Institute of India Pvt. Ltd. started a new plant in Pune, India.

Request sample copy here :  https://www.coherentmarketinsights.com/insight/request-sample/3864

 Request PDF brochure here: https://www.coherentmarketinsights.com/insight/request-pdf/3864

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions.

What we provide:

·        Customized Market Research Services

·        Industry Analysis Services

·        Business Consulting Services

·        Market Intelligence Services

·        Long term Engagement Model

·        Country Specific Analysis

Contact Us:   

Mr. Shah

Coherent Market Insights Pvt. Ltd.

Address: 1001 4th ave, #3200 Seattle, WA 98154, U.S.

Phone: +1-206-701-6702

Email : [email protected]